Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV003492150 | SCV000838973 | likely benign | Hereditary cancer | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000709365 | SCV001634104 | likely benign | Bloom syndrome | 2024-03-22 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256491 | SCV002529414 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-03-12 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV004997221 | SCV005624301 | uncertain significance | not provided | 2024-04-12 | criteria provided, single submitter | clinical testing | The BLM c.2556-8T>C variant has been reported in the published literature in an individual with breast cancer (PMID: 35264596 (2022)). The frequency of this variant in the general population, 0.000004 (1/250630 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on splicing yielded predictions that this variant does not affect BLM mRNA splicing. Based on the available information, we are unable to determine the clinical significance of this variant. |